Leading brokers name 3 ASX shares to sell

On Monday I had a look at a few shares that had been given buy ratings this week by leading brokers.

Today I thought I would look at the unfortunate shares that have received the dreaded sell rating.

Here are three shares that brokers think you should avoid:

Ainsworth Game Technology Limited (ASX: AGI)

According to a note out of UBS, its analysts have retained their sell rating but slashed the price target on the gaming technology company’s shares from $1.75 to just $1.09. The broker made the move after Ainsworth Game Technology made a surprisingly severe downgrade to its full-year earnings guidance. Although the company has blamed delays on the decline, UBS appears concerned that it could actually be the result of lower demand and market share for its products. I would agree with UBS on this one and think investors ought to give it a wide berth.

AMP Limited (ASX: AMP)

Another note out of UBS reveals that its analysts have downgraded AMP’s shares from a neutral rating to a sell rating. The broker has also made a cut to its price target, reducing it to $3.80 from $5.40. According to the note, the broker feels it could take upwards of three years for the company to rebuild its business following recent developments. Once again, I agree with UBS on AMP. While there may come a time when its shares offer a compelling risk/reward, I think they would need to fall notably lower from here to reach that level.

Medibank Private Ltd (ASX: MPL)

Analysts at Morgan Stanley have retained their underweight rating and reduced the price target on the health insurance company’s shares to $2.35. The broker believes that we may be on the verge of going through a period of low premium increases that could put significant pressure on health insurer margins. Morgan Stanley also has an underweight rating on industry peer NIB Holdings Limited (ASX: NHF). Considering how unaffordable health insurance is becoming for many people, I think the broker is spot on with its assessment.

Instead of buying the sell-rated shares above, I would buy these buy-rated star shares.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.